Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

Overview | Financials
Company Name Mirum Pharmaceuticals, Inc.
Symbol MIRM
Currency USD
Price 26.68
Market Cap 1,257,508,440
Dividend Yield 0%
52-week-range 23.14 - 35.56
Industry Biotechnology
Sector Healthcare
CEO Mr. Christopher Peetz
Website https://www.mirumpharma.com

An error occurred while fetching data.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome

Related Stocks

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

7.15 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

13.43 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

20.7 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

49.5 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.19 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

13.08 USD

National Research Corporation logo

National Research Corporation

NRC

25.25 USD

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

21.57 USD

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

1.16 USD

Financials

Numbers are in millions USD

Numbers are in millions USD